4.8 Article

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1009731107

关键词

-

资金

  1. Gates Foundation Grand Challenge in Global Health
  2. National Institutes of Health [AI054456, AI08080192, AI056299, AI73748, NS038037, NS045937, NS030843, NS054096]
  3. Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091204]
  4. National Multiple Sclerosis Society
  5. Juvenile Diabetes Research Foundation Center for Immunological Tolerance at Harvard University
  6. Ragon Institute of Massachusetts Institute of Technology
  7. Massachusetts General Hospital
  8. Harvard University
  9. National Institutes of Health
  10. Korea Health Promotion Institute [A091204] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Inhibitory receptors play a crucial role in regulating CD8 T-cell function during chronic viral infection. T-cell Ig- and mucin-domain-containing molecule-3 (Tim-3) is well known to negatively regulate T-cell responses, but its role in CD8 T-cell exhaustion during chronic infection in vivo remains unclear. In this study, we document coregulation of CD8 T cell exhaustion by Tim-3 and PD-1 during chronic lymphocytic choriomeningitis virus infection. Whereas Tim-3 was only transiently expressed by CD8 T cells after acute infection, virus-specific CD8 T cells retained high Tim-3 expression throughout chronic infection. The majority (approximately 65% to 80%) of lymphocytic choriomeningitis virus-specific CD8 T cells in lymphoid and nonlymphoid organs coexpressed Tim-3 and PD-1. This coexpression of Tim-3 and PD-1 was associated with more severe CD8 T-cell exhaustion in terms of proliferation and secretion of effector cytokines such as IFN-gamma, TNF-alpha, and IL-2. Interestingly, CD8 T cells expressing both inhibitory receptors also produced the suppressive cytokine IL-10. Most importantly, combined blockade of Tim-3 and PD-1 pathways in vivo synergistically improved CD8 T cell responses and viral control in chronically infected mice. Taken together, our study defines a parameter for determining the severity of CD8 T cell dysfunction and for identifying virus-specific CD8 T cells that produce IL-10, and shows that targeting both PD-1 and Tim-3 is an effective immune strategy for treating chronic viral infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据